Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment options
Cancer Treatment Reviews · 2026-11 · 150 · 103218
DOI: 10.1016/j.ctrv.2026.103218 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-11. Verfasst von Michela Palleschi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, Breast & GYN Unit IRCCS Istituto Romagnolo per lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, (FC), Italy. Electronic address…. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Italian Government Ministry of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Oncology, Breast & GYN Unit IRCCS Istituto Romagnolo per lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, (FC), Italy. Electronic address: michela.palleschi@irst.emr.it.
- Department of Medical Oncology, Gustave Roussy, Villejuif, France. Electronic address: alessandro.viansone@gustaveroussy.fr.
- Medical Oncology, Breast & GYN Unit IRCCS Istituto Romagnolo per lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, (FC), Italy. Electronic address: filippo.merloni@irst.emr.it.
- Medical Oncology, Breast & GYN Unit IRCCS Istituto Romagnolo per lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, (FC), Italy. Electronic address: caterina.gianni@irst.emr.it.
- Medical Oncology, Breast & GYN Unit IRCCS Istituto Romagnolo per lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, (FC), Italy. Electronic address: alberto.farolfi@irst.emr.it.
- Medical Oncology, Breast & GYN Unit IRCCS Istituto Romagnolo per lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, (FC), Italy. Electronic address: giulia.miserocchi@irst.emr.it.
Förderung
- Italian Government Ministry of Health
Zitieren
APA
Palleschi, M., Viansone, A., Merloni, F., Gianni, C., Farolfi, A., Miserocchi, G., Mariotti, M., Di Menna, G., Serra, O., Casadei, C., Sabbioni, S., Carlini, A., Montanari, D., Sirico, M., Mannozzi, F., Tegas, M., Cecconetto, L., Sarti, S., & Musolino, A. (2026). Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment options. Cancer Treatment Reviews, 150, 103218. https://doi.org/10.1016/j.ctrv.2026.103218
Vancouver
Palleschi M, Viansone A, Merloni F, Gianni C, Farolfi A, Miserocchi G, et al. Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment options. Cancer Treatment Reviews. 2026;150:103218. doi:10.1016/j.ctrv.2026.103218
BibTeX
@article{Palleschi2026,
author = {Palleschi, Michela and Viansone, Alessandro and Merloni, Filippo and Gianni, Caterina and Farolfi, Alberto and Miserocchi, Giulia and Mariotti, Marita and Di Menna, Giandomenico and Serra, Olga and Casadei, Chiara and Sabbioni, Simone and Carlini, Andrea and Montanari, Daniela and Sirico, Marianna and Mannozzi, Francesca and Tegas, Martina and Cecconetto, Lorenzo and Sarti, Samanta and Musolino, Antonino},
title = {Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment options},
journal = {Cancer Treatment Reviews},
year = {2026},
volume = {150},
pages = {103218},
doi = {10.1016/j.ctrv.2026.103218}
}
EUVIMED